Biocryst Pharmaceuticals (BCRX) Q3 2024 Earnings

Aug 5Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.31
-0.23
-0.14
-0.06

Details

Expected EPS
-0.173
Actual EPS
-0.06
Surprise EPS
0.11
Surprise Percent
+65.32%

Description

⁨Biocryst Pharmaceuticals⁩ (⁦BCRX⁩) has reported earnings of ⁦-0.06⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts